-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Harrow Acquires Global Rights to TYRVAYA(R), the First and Only FDA-Approved Nasal Spray for Dry Eye Disease

Dow Jones·08/06/2026 11:00:00

Please log in to view news